| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $758.7M | -1.9% |
| Cost of Revenue | $528.3M | -0.5% |
| Gross Profit | $230.4M | -5.0% |
| R&D Expense | $7.6M | -9.5% |
| SG&A Expense | $224.9M | +1.8% |
| Operating Income | -$29.3M | +51.5% |
| Interest Expense | $3.9M | -4.9% |
| Pre-tax Income | -$57.9M | +54.6% |
| Income Tax | $5.2M | -90.8% |
| Net Income | -$61.6M | +66.8% |
| EPS (Basic) | -$3.05 | +67.1% |
| EPS (Diluted) | -$3.05 | +67.1% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.9M | -21.6% |
| Accounts Receivable | $100.1M | -2.5% |
| Inventory | $123.3M | -4.4% |
| Current Assets | $394.2M | -3.0% |
| Total Assets | $1.02B | -9.8% |
| Current Liabilities | $193.5M | +17.2% |
| Long-term Debt | $5.3M | -99.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.4M | +146.0% |
| Capital Expenditures | $14.7M | +20.7% |
| Investing Cash Flow | -$2.7M | -101.9% |
| Financing Cash Flow | -$11.5M | +91.4% |
| Free Cash Flow | -$4.3M | +87.7% |
| Stockholders' Equity |
| $133.7M |
| -35.1% |